Vir Biotechnology Inc (VIR)
9.57
+0.20
(+2.13%)
USD |
NASDAQ |
Nov 05, 11:46
Vir Biotechnology Profit Margin (Quarterly): -73.95K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -73.95K% |
| June 30, 2024 | -14.71K% |
| March 31, 2024 | -127.5% |
| December 31, 2023 | -1.21K% |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | -301.6% |
| December 31, 2022 | -466.3% |
| September 30, 2022 | 47.20% |
| June 30, 2022 | |
| March 31, 2022 | 42.17% |
| December 31, 2021 | 64.87% |
| September 30, 2021 |
| Date | Value |
|---|---|
| June 30, 2021 | 35.53% |
| March 31, 2021 | -27.92K% |
| December 31, 2020 | -35.10K% |
| September 30, 2020 | -45.00K% |
| June 30, 2020 | -47.03% |
| March 31, 2020 | -15.86K% |
| December 31, 2019 | -17.19K% |
| September 30, 2019 | -20.39K% |
| June 30, 2019 | -39.45K% |
| March 31, 2019 | -168.6K% |
| December 31, 2018 | -439.9K% |
| September 30, 2018 | -29.35K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-73.95K%
Minimum
Sep 2024
64.87%
Maximum
Dec 2021
-14.48K%
Average
-837.1%
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 25.22% |
| Biomarin Pharmaceutical Inc | 14.22% |
| Arbutus Biopharma Corp | -1.15K% |
| GlycoMimetics Inc | -- |
| FibroGen Inc | -30.69% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -35.62% |
| Return on Assets | -29.88% |
| Return on Invested Capital | -35.62% |
| Gross Profit Margin (Quarterly) | 82.70% |
| Operating Margin (Quarterly) | -75.64K% |
| Return on Net Operating Assets | -280.9% |